Sodium oxybate-induced psychosis and suicide attempt in an 18-year-old girl

Journal of Child and Adolescent Psychopharmacology

Volumn 23, Issue 4, 2013, Pages 300-301

  Chien, Joseph ^a   Ostermann, Gina ^a   Turkel, Susan Beckwitt ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MODAFINIL; OXYBATE SODIUM;

ACUTE KIDNEY FAILURE; ADULT; AGITATION; AUDITORY HALLUCINATION; AUTOMUTILATION; BRAIN INFARCTION; CASE REPORT; DIGIT NECROSIS; DRUG DOSE INCREASE; ELECTROENCEPHALOGRAM; FEMALE; HEART ARREST; HEART INJURY; HOSPITAL ADMISSION; HUMAN; IRRITABILITY; LETTER; NARCOLEPSY; NECROSIS; NUCLEAR MAGNETIC RESONANCE IMAGING; PSYCHOSIS; SIDE EFFECT; SUICIDE ATTEMPT;

ADOLESCENT; FEMALE; HUMANS; NARCOLEPSY; PSYCHOSES, SUBSTANCE-INDUCED; SODIUM OXYBATE; SUICIDE, ATTEMPTED;

EID: 84878051824     PISSN: 10445463     EISSN: 15578992     Source Type: Journal    
DOI: 10.1089/cap.2012.0130     Document Type: Letter

References (16)

1. Alshaikh MK, Gacuan D, George S, Sharif M, BaHammam AS: Long-term follow-up of patients with narcolepsy-cataplexy treated with sodium oxybate (Xyrem). Clin Neuropharmacol 34:1-4, 2011.
2. Aran A, Einen M, Ling L, Plazzi G, Nishino S, Mignot E: Clinical and therapeutic aspects of childhood narcolepsy-cataplexy: A retrospective study of 51 children. Sleep 33:1457-1464, 2010.
3. Costanza CD, Hernandez M, Hernandez OJ, McDaniel CH: GHBinduced delirium: A case report and review of the literature on gamma hydroxybutyric acid. Am J Drug Alcohol Abuse 24:179-183, 1998.
4. Dyer JE, Roth B, Hyma BA: Gamma-hydroxybutyrate withdrawal syndrome. Ann Emerg Med 37:147-153, 2001.
5. Fuller DE, Hornfeldt CS: From club drug to orphan drug: Sodium oxybate (Xyrem) for the treatment of cataplexy. Pharmacotherapy 23:1205-1209, 2003.
6. Gahlinger PM: Club drugs: MDMA, gamma-hydroxybutyrate (GBH), rohypnol, and ketamine. Am Fam Physician 69:2619-2626, 2004.
7. Mamelak M: Narcolepsy and depression and the neurobiology of gammahydroxybutyrate. Prog Neurobiol 89:193-219, 2009.
8. Murali H, Kotagal S: Off-label treatment of severe childhood narcolepsy-cataplexy with sodium oxybate. Sleep 29:1025-1029, 2006.
9. Ortega-Ablás JJ, López-Bernabé R, Garc?́a ALS, Gómez JRD: Suicidal ideation secondary to sodium oxybate. J Neuropsychiatry Clin Neurosci 22:E26, 2010.
10. Pretty IA, Hall RC: Self-extraction of teeth involving gammahydroxybutyric acid. J Forensic Sci 49:1069-1072, 2004.
11. Rosenberg MH, Deerfield LJ, Baruch EM: Two cases of severe gamma-hydroxybutyrate withdrawal delirium on a psychiatric unit: Recommendations for management. Am J Drug Alcohol Abuse 29:487-496, 2003.
12. Rossetti AO, Heinzer RC, Tafti M, Buclin T: Rapid occurrence of depression following addition of sodium oxybate to modafinil. Sleep Med 11:500-501, 2010.
13. Sullivan SS: Narcolepsy in adolescents. Adolesc Med State Art Rev 21:542-555, 2010.
14. Tarabar AF, Nelson LS: The gamma-hydroxybutyrate withdrawal syndrome. Toxicol Rev 23:45-49, 2004.
15. The U.S. Xyrem-Multicenter Study Group: A randomized, double blind, placebo-controlled multicenter trial comparing the effects of three doses of orally administered sodium oxybate with placebo for the treatment of narcolepsy. Sleep 25:42-49, 2002. Xyrem-(sodium oxybate) oral solution. Palo Alto, Calif: Jazz Pharmaceuticals, Inc. 2008. http://www.xyrem.com/xyrem-pi.pdf.
16. Zvosec DL, Smith SW: Agitation is common in c-hydroxybutyrate toxicity. Am J Emerg Med 23:316-320, 2005.